Skip to main content
. 2018 Jun 15;6(2):167–175. doi: 10.1016/j.gendis.2018.05.005

Table 1.

Effect of Sertraline, Meloxicam, Caffeic acid on monoamine neurotransmitter together with their precursor amino acids and metabolites (mean ± s, n = 5, μg/g).

Tyr MHPG NE 5-HIAA Trp DA DOPAC HVA
Control 41.80 ± 9.19 1.50 ± 0.36 0.94 ± 0.05 0.19 ± 0.02 3.28 ± 0.57 0.15 ± 0.05 0.36 ± 0.04 0.18 ± 0.02
CUMS 123.71 ± 12.53 2.41 ± 0.48 0.74 ± 0.06 0.24 ± 0.03 5.08 ± 1.07 0.58 ± 0.19 0.33 ± 0.07
Sertraline 5 mg/kg 128.09 ± 9.77 2.48 ± 0.31 0.65 ± 0.13 0.14 ± 0.01# 10.38 ± 0.72#
Meloxicam 3 mg/kg 103.76 ± 7.87# 2.42 ± 0.28 0.81 ± 0.15 0.17 ± 0.02# 6.09 ± 1.68 0.22 ± 0.06# 0.13 ± 0.01#
Meloxicam 1 mg/kg 93.71 ± 4.38# 1.82 ± 0.32# 0.67 ± 0.05# 0.16 ± 0.02# 5.84 ± 0.47 0.18 ± 0.06# 0.13 ± 001#
Caffeic acid 30 mg/kg 52.96 ± 7.55# 2.27 ± 0.39 0.80 ± 0.05# 0.15 ± 0.03# 3.62 ± 0.23# 0.08 ± 0.01#
Caffeic acid 10 mg/kg 42.13 ± 8.50# 1.77 ± 0.42# 0.62 ± 0.01# 0.18 ± 0.04# 4.90 ± 0.93 0.18 ± 0.04#
Meloxica + Caffeic acid 109.09 ± 6.93# 1.95 ± 0.23# 0.61 ± 0.08# 0.17 ± 0.03# 8.43 ± 0.80# 0.45 ± 0.16# 0.23 ± 0.01#

Table note: *, P < 0.05, VS control group; #, P < 0.05, VS CUMS group.